Deep learning-based histologic classifiers enable molecular subtyping of metastatic prostate cancer.
AI learns to classify aggressive prostate cancers from routine slides with 92% accuracy, potentially speeding diagnosis.
NEURAL-PC, a deep learning model using interpretable cellular features and multiple instance learning on H&E histology, classifies neuroendocrine prostate cancer with AUROC 0.921 in independent external validation. This record was retained from the prior triage attempt for PubMed pipeline handoff.
What the study was
- Study design
- validation_study
- Category
- Diagnostics
- Maturity
- Validated
- Journal
- JCI Insight
Why it surfaced
Accurately diagnosing NEPC is critical but currently requires expensive molecular assays; histology-based DL model validated externally at AUROC 0.921 across major cancer centers addresses a concrete clinical bottleneck in mCRPC management.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.